Quantinno Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Quantinno Capital Management's BMY Position: Q1 2026 in Review
Quantinno Capital Management increased its Bristol-Myers Squibb (BMY) stake by 24% in Q1 2026, buying an estimated $9.93M and bringing the position to 875,068 shares worth $53.1M. The position accounts for 0.09% of the portfolio, ranked #256.
Quantinno Capital Management first reported a position in BMY in Q4 2018 and has held it in 19 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Quantinno Capital Management held 875,068 shares of Bristol-Myers Squibb worth $53.1M as of Q1 2026.
- Quantinno Capital Management bought 170,317 Bristol-Myers Squibb shares in Q1 2026, an estimated $9.93M.
- Bristol-Myers Squibb made up 0.09% of Quantinno Capital Management's portfolio in Q1 2026, its #256 holding.
- Quantinno Capital Management first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 19 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.